교보문고 SCHOLAR 스콜라
이 자료는 국가지식 연계기관과의 협약에 따라 무료로 제공됩니다.
원문을 이용하시기 위해서는 연계기관의 정책을 따르고 있으니
궁금하신 사항은 연계기관을 통해 문의하시기 바랍니다.
곧 연계기관으로 이동합니다
본문내용 바로가기
홈 > 간행물 권호
  • 발행기관: 대한갑상선-내분비외과학회
  • 간행물:
  • 권/호:

The Koreran journal of Endocrine Surgery(The Koreran journal of Endocrine Surgery)

  • 발행기관 : 대한갑상선-내분비외과학회(The Korean Association of Endocrine Surgeons)
  • 출처구분 : 학회
  • 간행물유형 : 학술저널
  • 발행주기 : 계간 (발행월:3,6,9,12)
  • Print ISSN : 1598-1703
  • Online ISSN : 2287-6782
  • 등재정보 : KCI 등재
The Koreran journal of Endocrine Surgery
검색결과 =
3
Betamethasone to Prevent Symptomatic Hypocalcaemia and Other Complications after Total Thyroidectomy: a Case-control Study
Betamethasone to Prevent Symptomatic Hypocalcaemia and Other Complications after Total Thyroidectomy: a Case-control Study
Marcello Picchio;Annalisa Romina Di Filippo;Martina Spaziani;Simone Orelli;Riccardo Bellagamba;Giuliano Guttoriello;Alessandro De Cesare;Erasmo Spaziani
대한갑상선-내분비외과학회 / 대한내분비외과학회지21권3호 / 2021 / 61-69 (9 pages)
의약학>일반외과학 / KDC : 기술과학 > 의학 / KCI : 의약학 > 일반외과학
초록보기
Purpose: The study aims to determine whether postoperative infusion of betamethasone reduces the risk of symptomatic hypocalcaemia (SHC) and other complications after total thyroidectomy. Methods: We compared a group of patients receiving betamethasone (beta group) postoperatively to a group without any perioperative glucocorticoid infusion (no beta group). Plasma levels of parathyroid hormone, total calcium, and C-reactive protein (CRP) were measured pre- and postoperatively. Complications were recorded within a 30-day follow-up. Postoperative SHC was the primary outcome. Results: In the beta group and the no beta group, 54 patients and 47 patients were included, respectively. In the beta group, the incidence of SHC (4 pts vs. 14 pts in the no beta group; P=0.003) was reduced. In the beta group, serum calcium levels were higher on postoperative day 1 (8.6 mg/dL vs. 8.2 mg/dL in the no beta group; P=0.001) and day 2 (8.7 mg/dL vs. 8.1 mg/dL in the no beta group; P<0.000). In the beta group, serum C-reactive protein levels were lower postoperatively. In a univariate analysis, American Society of Anaesthesiology score > I (odds ratio [OR], 0.19; P=0.002), no betamethasone treatment (OR, 0.19; P=0.006), and parathyroid glands remaining in situ (PGRIS) score <3 (OR, 6.00; P=0.005) were related to postoperative SHC; in a multivariate analysis, betamethasone treatment (OR, 0.09; P=0.007) and PGRIS score <3 (OR, 8.41; P=0.045) were related to postoperative SHC. No difference was observed in postoperative complications. Conclusion: Postoperative use of betamethasone reduces the incidence of SHC after thyroid surgery without affecting other complications.
Laparoscopic Retroperitoneoscopic Removal of an Adrenal Hemangioma: a Case Report
Laparoscopic Retroperitoneoscopic Removal of an Adrenal Hemangioma: a Case Report
Kristin McCoy;Katherine Howe;Daniel Tershak
대한갑상선-내분비외과학회 / 대한내분비외과학회지21권3호 / 2021 / 70-74 (5 pages)
의약학>일반외과학 / KDC : 기술과학 > 의학 / KCI : 의약학 > 일반외과학
초록보기
Adrenal hemangiomas are a benign tumor of the adrenal gland. These are usually found incidentally on imaging. They are a rare entity of adrenal tumors which have been documenting in the literature in under 100 reports. The diagnosis is routinely made on post-operative histology. We present a case of a 63-year-old male with a right adrenal nodule increasing in size. Computed tomography scan demonstrated a 4.0 cm lesion. He underwent surgical resection due to its enlargement through a retroperitoneoscopic approach. Pathology examination revealed the diagnosis of an adrenal hemangioma. Adrenal hemangioma is a rare entity of benign adrenal tumors but should be considered in your differential diagnosis of adrenal incidentalomas. The treatment of choice is surgical resection for confirmative diagnosis and to rule out a malignant lesion.
Renal Cell Carcinoma Metastasis to Thyroid, Presenting Like Non-toxic Multi Nodular Goiter
Renal Cell Carcinoma Metastasis to Thyroid, Presenting Like Non-toxic Multi Nodular Goiter
HaengJin Ohe;Kyeong Woon Choi;Yeo Goo Chang
대한갑상선-내분비외과학회 / 대한내분비외과학회지21권3호 / 2021 / 75-78 (4 pages)
의약학>일반외과학 / KDC : 기술과학 > 의학 / KCI : 의약학 > 일반외과학
초록보기
Theoretically, metastatic renal cell cancer (RCC) is able to metastasize well to organs with a rich blood supply, but thyroid with a good vascularity is known to be a site with rare metastasis of RCC. Distant metastasis of RCC may also occur several years after its first diagnosis. Therefore, there is a high possibility of overlooking metastatic RCC to thyroid. To avoid this, we have to take the patient s past history in detail, and to keep in mind that the distant metastasis of RCC could be occurred in the thyroid years later.